The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials.
about
A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicinesWhy is Research on Herbal Medicinal Products Important and How Can We Improve Its Quality?A novel method using confocal laser scanning microscopy for sensitive measurement of P-glycoprotein-mediated transport activity in Caco-2 cells.Herb-drug interactions: an overview of systematic reviews.Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations.Depression in cancer patients: Pathogenesis, implications and treatment (Review).Quality and safety of herbal medical products: regulation and the need for quality assurance along the value chains.Pharmacokinetic Interactions between Drugs and Botanical Dietary Supplements.Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.Factors affecting polyphenol biosynthesis in wild and field grown St. John's Wort (Hypericum perforatum L. Hypericaceae/Guttiferae).Pharmacological modulation of diacylglycerol-sensitive TRPC3/6/7 channels.Potential of St John's Wort for the treatment of depression: the economic perspective.Interactions between herbs and antidiabetics: an overview of the mechanisms, evidence, importance, and management.St. John's Wort Potentiates anti-Nociceptive Effects of Morphine in Mice Models of Neuropathic Pain.St. John's wort relieves pain in an animal model of migraine.St John's wort (Hypericum perforatum)-induced psychosis: a case reportSt John's wort greatly reduces the concentrations of oral oxycodone.Reversal of NO-induced nociceptive hypersensitivity by St. John's wort and hypericin: NF-κB, CREB and STAT1 as molecular targets.Patterns of complementary and alternative medicine (CAM) use among dental patients.St John's wort greatly decreases the plasma concentrations of oral S-ketamine.Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo.Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance.
P2860
Q21090750-027FCCC4-7CEC-4A7E-8BB8-27933DA1367FQ33657605-11688206-AB9F-4174-A569-C408446EEA14Q33947052-9EEBD664-46DE-4639-9593-F1F00D6824E1Q34279245-9F9876D7-E399-4BD6-86AD-D06C0A6E584EQ35009679-AB7E41F1-00D3-4859-8DE0-E8F90DD750B1Q35167892-078E711A-399C-483F-9515-89CC9B09F36EQ35541589-CEAA52FE-4542-41CA-B56C-5D2DCEA69157Q36502919-5355F475-F648-459C-8D5C-146F20378404Q36926307-56B994C8-B4F6-4B8D-9D37-B8CF08A74E8EQ37391965-97275116-AAAF-48B0-AB53-4A77E0D3CD31Q37798861-2669C634-F99C-4F2A-B340-269422D02F1FQ37803219-A39F9D39-6335-439E-8EA6-2A07288674E3Q38283110-115AC9E4-685D-4A9C-8DEA-0BD477DCC2ABQ39166639-A06C14BD-209C-4F37-AB65-C7F6C8354547Q39238341-2FC46C60-87A0-474C-A9D9-F329D165835FQ41850133-B8EDF921-FA74-4E7D-BAC8-9279666024A6Q43182631-E53CBBF8-F590-4F30-AAC8-7CE134E98B7EQ44177660-03D726E1-4834-437A-85FE-58D95584D0B4Q48251616-F285213B-165D-49AE-9D09-38C4808845D3Q48258575-E341EB4B-530E-429C-A1C8-B53EA64A9953Q48598672-570DA89E-B8CF-492B-B5C8-318D37458C17Q49719637-4F4BCE46-74DF-494E-A0A1-F77535871DCA
P2860
The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The effect of St John's wort e ...... f prospective clinical trials.
@ast
The effect of St John's wort e ...... f prospective clinical trials.
@en
type
label
The effect of St John's wort e ...... f prospective clinical trials.
@ast
The effect of St John's wort e ...... f prospective clinical trials.
@en
prefLabel
The effect of St John's wort e ...... f prospective clinical trials.
@ast
The effect of St John's wort e ...... f prospective clinical trials.
@en
P2093
P2860
P1476
The effect of St John's wort e ...... f prospective clinical trials.
@en
P2093
D L Whitten
H Wohlmuth
J A Hawrelak
P2860
P304
P356
10.1111/J.1365-2125.2006.02755.X
P407
P577
2006-09-29T00:00:00Z